Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
Research.Patient.info

Adrenoleukodystrophy research hub

2 indexed studies · 1 currently recruiting

  • authorisedHuman Pharmacology (Phase I)- First administration to humans

    OPEN-LABEL, PHASE I CLINICAL TRIAL TO EVALUATE THE SAFETY AND PRELIMINARY CLINICAL RESPONSE TO THE USE OF ALLOGENEIC BONE MARROW MESENCHYMAL STEM CELLS IN CHILDREN AND ADOLESCENTS WITH X-LINKED ADRENOLEUKODYSTROPHY CEREBRAL FORM.

    This early-stage study is testing a new stem cell treatment for boys and young men with cerebral adrenoleukodystrophy (ALD). Researchers want to see if cells taken from healthy bone marrow are safe, well-tolerated, and able to help slow down damage to the brain caused by this rare condition.

    Spain
  • recruitingHuman Pharmacology (Phase I)- Other

    A PHASE 1, OPENLABEL, SINGLECENTER STUDY TO EVALUATE DRUGDRUG INTERACTIONS WITH GEMFIBROZIL, ITRACONAZOLE, AND CARBAMAZEPINE AND THE FOOD-EFFECT ON ORAL LERIGLITAZONE IN MALE HEALTHY SUBJECTS

    This study is looking at how a new drug, leriglitazone, behaves in the body of healthy men. It checks if other common medicines or food affect how leriglitazone works. This helps us understand its safety and effectiveness for conditions like Adrenoleukodystrophy.

    Poland
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.